Abstract:Background: As the most commonly used illicit substance, cannabis is gaining global acceptance through increasing legalization efforts. This shift intensifies the need for research to guide policymakers and healthcare providers in harm reduction and treatment strategies. Nonetheless, the relationship between psychopathological symptoms and cannabis use remains inadequately understood. Methods: A sample of regular cannabis consumers completed self-reported assessments for depression (Patient Health Questionnaire-9), anxiety (General Anxiety Disorder-7), Attention-Deficit/Hyperactivity Disorder (ADHD; Adult ADHD Self-Report Scale V1.1), and psychosis (Early Recognition Inventory based on IRAOS) as well as previous black-market cannabis use patterns. Cannabis Use Disorder Identification Test Revised (CUDIT-R) was used to identify cannabis use disorder (CUD). To understand psychopathological symptom load related to cannabis consumption as well as cannabis use motives, multiple regression models were performed to identify psychopathological variables predicting cannabis use frequency and quantity. Linear regression and correlation analyses were conducted, adjusting for relevant covariates (age, gender, education, alcohol, other substance use). Results: Three-hundred-sixty regular cannabis users interested in a study on regulated cannabis access in Basel, Switzerland were examined. In bivariate analysis, cannabis use frequency correlated with depressive (r(358) = 0.16, p = 0.003) and anxiety symptom load (r(358) = 0.11, p = 0.034). Cannabis quantity correlated with depressive (r(358) = 0.15, p = 0.005), ADHD (r(358) = 0.14, p = 0.008), and psychosis symptom load (r(358) = 0.16, p = 0.002). However, in the adjusted regression models only depressive and ADHD symptom loads were significantly associated with cannabis use frequency (p = 0.006 and p = 0.034, respectively) and quantity (p = 0.037 and p = 0.019, respectively). No significant correlations between cannabis consumption and anxiety or psychosis remained after adjustment. Conclusion: ADHD and depressive symptoms correlate with increased cannabis use in a cohort of regular users, suggesting potential self-medication in nonclinical populations. With the rising availability of cannabis worldwide, these results highlight the necessity for longitudinal studies to disentangle the complex dynamics between cannabis consumption and mental health symptoms.

Cannabis Use at A Young Age is Associated with Psychotic Experiences

Cannabis Use and Subclinical Positive Psychotic Experiences in Early Adolescence: Findings from a Dutch Survey.

Age-dependent association of cannabis use with risk of psychotic disorder

INITIAL AGE AND AMOUNT OF CANNABIS EXPOSURE ARE STRONGLY ASSOCIATED WITH PSYCHOSIS VULNERABILITY IN A SAMPLE OF 18,000 DUTCH ADOLESCENTS

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls

Cannabis Use and Age at Onset of Schizophrenia

Adolescent exposure to Δ 9 -tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons

Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.

Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years

Cannabis Use As An Indicator Of Risk For Mental Health Problems In Adolescents: A Population-Based Study At Secondary Schools

Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.

Cannabis Use is a Better Indicator of Poor Mental Health in Women Than in Men: a Cross-Sectional Study in Young Adults from the General Population.

Association between cannabis and psychiatric hospitalization.

Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study

Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults.

Cannabis Use and Psychosis: A Longitudinal Population-based Study

Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

Cannabis-Associated Psychotic-Like Experiences Are Mediated by Developmental Changes in the Parahippocampal Gyrus.

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence from the Population-Based World Health Organization World Mental Health Survey Initiative.